Richard Buxton and Philip Matthews have both slipped into the bottom quartile of the UK All Companies sector on a six-month view following their moves to Old Mutual and Schroders respectively.
GlaxoSmithKline, the UK's largest pharmaceutical group, has agreed to sell one of its businesses to rival Novartis, in a deal which will see it return billions of pounds to shareholders.
Other Equities articles
Google shares moved sharply lower in after-hours trading following a disappointing update, with the negative sentiment that has blighted the sector showing no sign of abating.
Hargreaves Lansdown has said Neil Woodford's new fund management venture could provide a further boost to its business after it reported record net inflows of £1.83bn for the first quarter.
Groundbreaking social network service Facebook is set to expand into financial services, according to reports.
The Nasdaq index suffered its worst day since 2011 yesterday, dropping over 3% as investors continued to switch out of technology and biotechnology holdings.
The chief executive of AFH Financial has sold off a significant stake, about £760,000, in the business after its recent AIM listing.
James Burns, manager of Smith & Williamson’s MM Cautious Growth fund, tells Rebecca Jones why he is happy to forego income for capital growth using zero dividend preference shares...
Anthony Bolton has said he feels his final year in charge of the Fidelity China Special Situations investment trust has 'vindicated' his decision to come out of retirement.
Invesco Perpetual has announced that Mark Barnett's Invesco Perpetual High Income fund will move out of the IMA Equity Income sector and into the IMA UK All Companies sector on 31 March.
Invesco Perpetual has made three appointments to its UK equities team.
Most read articles
Most commented articles
Job of the week